John W. Kozarich, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 467 shares at $178.41 ($84K) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($84k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $177.60 | 24 | $4K | 5.1% |
| 2 | $178.41 | 196 | $35K | 41.7% |
| 3 | $180.01 | 155 | $28K | 33.3% |
| 4 | $181.18 | 92 | $17K | 19.9% |
| Total | $179.45 avg | 467 | $84K | 100% |
| Filing → |
| LGND | SELL | 2026-03-04 | $179K | — | Filing → |
| LGND | SELL | 2026-02-04 | $175K | — | Filing → |
| LGND | SELL | 2026-01-06 | $173K | — | Filing → |